Janux Therapeutics, Inc. (JANX) analyst actions
Rating and price-target actions on JANX in the public-source dataset. Wires and filings carry few rating actions, so this list is sparse by nature — the hub's by-event-type table holds the measured analyst base rates. Back to the JANX overview →
1 measured JANX analyst action event.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Janux Therapeutics Initiates Phase 1b Expansion Studies with JANX007 in Patients with Prostate Cancer and Provides Program Updates | Press release | +0.52% | -0.70% |
Keep exploring
More JANX: earnings → · SEC filings → · JANX overview →